SC9 Flashcards Preview

SCRA > SC9 > Flashcards

Flashcards in SC9 Deck (42):
1

what is haematopoiesis

when HSCs give rise to all other blood lineages, including myeloid and lymphoid progeny

2

describe Haematopoesis in development

occurs in wave
1st wave: occurs in yolk sac outside of the embryo (cannot engraft) and then enter the embryo via the vasculature
2nd wave: occurs in the liver (more proliferative than adult SCs) highly enriched cells
3rd wave: occurs as soon as bone cavity is formed, SC colonise and become productive

3

what are the first difintive HSCs and where are they found

- definitive: found early as possible in development and can be transplanted into irradiated mouse.
** intraembryonics HSCs: develop in the aorta gonad mesenephros (AGM) region.
on the floor of the dorsal aorta which is surrounded by mesenchymal cells.
In this region some of the endothelial cell develop into HSCs moving in circulation.

4

Describe the experiment showing new HSC emergence in zebra fish embryo

used non invasive high resolution imaging of live zebra fish embryos to show that HSCs emerge directly from the endothelium of the aortic floor.
* in this model the developing SCs pulls adjacent cells together to maintain the vessel and then the newly formed HSCs move away.

5

how does zebra fish embryonic HSC differ from mammal

in mammals new HSC go to the blood stream, in fish HSCs just move away.

6

why are zebra fish useful in study of development

as they are transparent so development can be seen in vivo.

7

what happens in adult haematopoesis

HSCs give rise to all cell types in haemtopoetic system.

8

what is the current understanding of haemotopoiesis lineages

original understanding was that the system was strictly heirachal, with lineages being related in certain ways.
however now believe there are more routes than original predicted.
for example the common myeloid progenitoy may not exist in reality and may actually be 19 sub populations.
the exact route from a stem to a differentiated cell can vary.

9

give an example of a HSC regulation factor

HoxB4: homeobox gene: positive regulator of self-renewal and expansion.
ES and iPSC have high levels

10

give two examples of HSC TFs

1. Gfi1: negative regulator of HSC proliferation. KO leads to HSC that proliferate more.
2. c-myc: promotes differentiation and proliferation

11

give three examples of HSC cell cycle inhibitors and what are they?

proteins involved in maintaining SC quiescence and preserving from aging.
p21, p27 and p16

12

what does p21 do in HSCs

inhibits HSC cycle
p21 KO mice rapidly lose HSC due to their fast proliferation and exhaustion.
`

13

what does p27 do in HSCs

does not affect HSCs directly
but p27 KO have an expanded progenitor pool

14

what does p16 do in HSCs

KO leads to reduction of HSC in young mice but rescues HSCs in old mice

15

what are two examples of chromatin and histone modifiers of HSCs

Bmi-1 and MII

16

what does Bmi-1 do in HSCs

polcomb gene neccessary for maintenance of Lt-HSC. KO loses HSC rapidly

17

what does MII do in HSCs

tritorax gene
neccessary for HSC development.
MII deletion in adult mice leads to no overt phenoptype, however MII deficient BM fails to reconstitute recipient mice.

18

give an example of mircoRNA processing in HSCs

DICEE
essential for HSC persistance in vivo.
In particular, Mir-125a controls HPC apoptosis by down regulating pro-apoptotic genes such as Bak1.

19

give an example of a tumour suppressor in HSCs

PTEN: indispensable in HSC maintenacne (but not leukemia maintainence).

20

How is the haemotopoietic system robust?

lots of redundant systems.
KOs often have no phenotypes until stress is applied.
Treatment for therapy targets therefore need to be important for Leukemia cells than healthy HSCs. CD44 KOs can engraft into normal HSCs byt not leukemia

21

How can HSC fitness be tested

Competative BM transplantation

22

describe a competitive BM transplantation

1. BM mixed 1:1 from competitor mouse with CD45.1 or with a donor mouse (either a WT control or altered (KO)) CD45.2. injected into CD45.1 mouse.
2. Host is irradiated so injected BM repopulates system
3. flow cytometry can identify how many cells are CD45.1/2 using Abs.
4. can test how altered KO SC are doing compared to control at repopulating tissue.
5. control mice have 50:50 reconstitution.

23

why would the BM from another mouse not be rejected

as HSC niche is an immuno priveledged site.

24

Describe serial transplant and why it is useful

alter cells in BM and move into a recipient, remove and repeat then looking for results for tertiary recipient.
-- allows for subtler phenotypes to be shown.

25

give an example of a subtler phenotype only shown via serial transplants

DK11 - wnt signalling inhibitor by competing for receptors.
initially mice have no phenotype but after serial transplantation/stress the recipients dont survive therefore inhibition of self-renewal occurs

26

Why are wnt signalling pws difficult to study

due to a high activity in a no. of systems/ dose dependencay

27

Give an example of a KO that has no apparent phenotype and 4 reasons why this is unexpected

beta (alpha/gamma) catenin KO
unexpected due to related activity of:
1. tumour suppressor APC
2. GSK3 beta
3. Dkk1
4. wnt pws

28

how does tumour suppressor APC involve beta catenin and how is it important for HSCs

regulates the function of HSCs through a beta catenin paw and is indispensable for HC survival.

29

how does GSK3 beta involve beta catenin and how is it important for HSCs

key enzyme in wnt signalling, it phosphorylates beta catenin leading to its degradation.
GSK3beta inhibitors increase HSC ability to repopulate transplanted recipients by expanding progenitors and reatining HSCs.

30

how does Dkk1 involve beta catenin and how is it important for HSCs

dk11 inhibits wnt/beta catenin pw via reduction in beta catenin and increase in OCT4 expression.
Expression of Dkk1 by osteoblasts impairs HSC function.

31

why is wnt signalling important for HSCs

wnt stimulates self-renewal of atleast a sub-population of HSCs.
wnt signalling levels need to be within optimum levels.

32

how do osteoblasts support HSC generation

by secreting GFs

33

what affect does killing off osteoblasts with suicide genes and ganciclovir have on BM

BM empties out, however repopulation is still possible.

34

what is PTH and what does it do

a hormone important in bone remodelling treatment expands the osteoblast compartment and HSC pool via Notch signalling.

35

what is BMP cytokine and what does it do

BMP cytokine = bome morphogenic protein.
signalling regulates osteoblast no. and HSC no.

36

what does colagen1.3 TK do

ablates osteoblast population and severely alters BM hematopoesis, reversible so not all HSCs must be ablated.

37

what does in vivo imaging of HSC injection into irradiated and non irradiated mice show

in non irradiated: HSCs dont engraft and are further away from osteoblasts
in irradiated: HSCs engraft and are closer to osteoblasts and vessels

38

What are the two hypothesised niches hor HSCs

endosteal niche
vascualture niche
*osteoblasts and blood vessels both seem to be important.

39

what is the initial working model for the HSC niche

quiescent SCs are found close to osteoblasts and move towards the central marrow while differentiating.

40

what is the current working model for for HSC niche

specific types of vessels are found in both HSCs and mesenchymal cells and regulate hematopoesis.
* LT-HSC (long term): preferentially localise near osteoblasts.
* endosteum vessels are surrounded by Nestin+ mesencymal cells (SC marker) and very closely asssociated with HSCs

41

what are mesenchymal cells

in vivo: give rise to bone/cartilage and fat
in vitro: give rise to all plus astrocytes/fibroblasts and myocytes.
* still difficult to identify - bad marker (selection is via good adherance to plastic)

42

what are the therapeutic applications for mesenchymal BM cells

1. have good anti-inflammatory function and improve BM engraftent.
2. Also improve results of several therapies with good immunomodulatory effect.
3. however have very poor homing to BM and reside only transiently in lung and spleen and dont engraft there.